Clinical Trial Update: Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia [Phase 2]

View source ↗

Summary

Phase 2 trial of green tea extract in current or former smokers with bronchial dysplasia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Dysplasia
• Lung Cancer

Drugs mentioned

• Green Tea Extract (Camellia sinensis extract)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Lung Cancer, Precancerous Condition | Phase 2 | Status: TERMINATED